Episode 13: Graeme Bradshaw on Non-Alcoholic Fatty Liver Disease and NASH
Release Date: 08/19/2020
Episode 23: PART 1 Key Cellular Mechanism that Influence Gut Health and Treatment Options
The INL Podcast
In this two-part episode, Dr Michael Osiecki PhD and Managing Director of Bio Concepts joins INL’s Founder Graeme Bradshaw for an in-depth visual discussion about gut health at a cellular level.
info_outline
Episode 22: The Role of High Potency Probiotics in Chronic Health Treatment Protocols
The INL Podcast
Gina Patrick, INL's Director of Sales and Marketing joins Graeme Bradshaw to discuss the most researched probiotic formula in the clinical setting, the De Simone Formulation. Backed by over 70 clinical RCT's, covering a wide demographic of patients.
info_outline
Episode 22: The Role of High Potency Probiotics in Chronic Health Treatment Protocols
The INL Podcast
Gina Patrick, INL's Director of Sales and Marketing joins Graeme Bradshaw to discuss the most researched probiotic formula in the clinical setting, the De Simone Formulation. Backed by over 70 clinical RCT's, covering a wide demographic of patients.
info_outline
Episode 21: H.pylori Practitioners Q&A
The INL Podcast
In this episode, Alan Patrick from AMS joins INL's Founder Graeme Bradshaw to discuss the epidemiology of H.Pylori. They cover how to measure H.Pylori, what the different methods of diagnostic testing show and what the results would mean for clinical application. They discuss what it means when low levels are detected, the clinical decision-making process and how you can use H.Pylori as a barometer for digestive function, which is crucial for solving the root cause of many digestive conditions.
info_outline
Episode 21: H.pylori Practitioners Q&A
The INL Podcast
In this episode, Alan Patrick from AMS joins INL's Founder Graeme Bradshaw to discuss the epidemiology of H.Pylori. They cover how to measure H.Pylori, what the different methods of diagnostic testing show and what the results would mean for clinical application. They discuss what it means when low levels are detected, the clinical decision-making process and how you can use H.Pylori as a barometer for digestive function, which is crucial for solving the root cause of many digestive conditions.
info_outline
Episode 20: Dr. Tim Trodd's Functional Medicine Approach To Uncovering Important Clues To Identify the Individual Needs for ASD Patients
The INL Podcast
Graeme is joined by Dr Tim Trodd. Together they explore Dr Trodd's approach to managing ASD patients by addressing key deficiencies, the role of Methylation and how key metabolite and cofactors levels give important clues as to how to uncover individual needs beyond standard MTHR gene variant testing. They share experiences on how modern-day living has multiple triggers for high systemic inflammation, oxidative stress and epigenetic factors that have set the stage for the rise in neuroinflammatory cases.
info_outline
Episode 19: Diagnostic Solutions GI Map Comprehensive Stool Testing; Practitioners Q&A
The INL Podcast
In this episode, Alan Patrick from AMS joins INL's Graeme Bradshaw to discuss practitioners' FAQ's on best practices for interpretation of GI Map.
info_outline
Episode 18: Graeme Bradshaw SIBO Q&A
The INL Podcast
In this episode, Alan Patrick from Asia Medical Solutions joins IMI and INL's Founder Graeme Bradshaw to discuss practitioners' frequently asked questions on best practices for treating patients with Small Intestinal Bacterial Overgrowth (SIBO).
info_outline
Episode 17: Graeme Bradshaw on how to improve sleep
The INL Podcast
For today’s discussion, we look at the treatment of sleep. For most it’s easily dealt with but for some it can become a chronic life long issue and in this episode Graeme discusses key treatment considerations, perhaps most importantly when the best time to use Melatonin would be as well as some of the underused herbs that can have a huge effect on the brain without the heavier toxic side effects and dependancy issues of pharmaceutical interventions.
info_outline
Episode 16: Dr Vanessa Wong on Mental Health
The INL Podcast
In this episode of the INL podcast we are joined by a very special guest, psychiatrist Dr Vanessa Wong.
info_outlineFor today’s discussion, we move on from detoxification and explore the two most prevalent liver diseases, non-alcoholic fatty liver disease and it’s more aggressive sibling, NASH or Non-Alcoholic—Steato-Hepatitis.
Just fatty liver on it’s own is estimated to have a worldwide prevalence of 25%. In Hong Kong this number is lower at around 14% but the progression towards fibrosis and NASH is increasing quickly, with some case showing signs of NASH in just three years.